Skip to main content

Table 4 Transplant characteristics, surgical factors, and post-surgical complications

From: Intraoperative glycemic control in patients undergoing Orthotopic liver transplant: a single center prospective randomized study

 

Current standard of care (N = 50)

Strict glucose control (N = 50)

P-Value

Transplant Characteristics and Surgical Factors

 High Risk Donor

5 (10.0)

7 (14.0)

0.538

 Warm Ischemic Time (Minutes)

26.0 [23.0 to 32.0]

27.0 [23.0 to 33.0]

0.916

 Cold Ischemic Time (Minutes)

400.0 [323.0 to 488.0]

385.5 [333.0 to 429.0]

0.572

 Total Ischemic Time (Minutes)

431.0 [354.0 to 522.0]

415.5 [367.0 to 455.0]

0.575

 Total Surgical Time (Minutes)

313.0 [281.0 to 369.0]

329.9 [307.0 to 375.8]

0.228

Intraoperative Blood Product Usage

 Packed red cells (mL)

2450.0 [1050.0 to 3850.0]

2450.0 [1400.0 to 3500.0]

0.475

 Platelets (mL)

500.0 [500.0 to 750.0]

625.0 [375.0 to 750.0]

0.667

 Cryoprecipitate (mL)

200.0 [100.0 to 200.0]

200.0 [100.0 to 400.0]

0.438

 Cell Saver (mL)

999.0 [500.0 to 1425.0]

848.0 [700.0 to 1600.0]

0.645

  1. Data are presented as frequency (%) or median [25th percentile to 75th percentile], as needed